Phase II TELESTO: Deferasirox vs Placebo in Patients With Low-/Intermediate-Risk Myelodysplastic Syndromes and Iron Overload

On-demand webcast from an ASH 2022 satellite symposium on BTK inhibitors for patients with CLL and MCL, from Clinical Care Options (CCO)

Jeff Sharman, MD
Program Director Ian W. Flinn, MD, PhD Susan M. O'Brien, MD Physicians: maximum of 2.0 AMA PRA Category 1 Credits™ Released: January 31, 2023 Expired: January 30, 2024

On-demand webcast from an ASH 2022 satellite symposium on asparaginase for the treatment of AYA and adult acute lymphoblastic leukemia, from Clinical Care Options (CCO)

Daniel J. DeAngelo, MD, PhD
Program Director Emily Curran, MD Kjeld Schmiegelow, MD, DMSci Physicians: maximum of 2.0 AMA PRA Category 1 Credits™ Released: January 30, 2023 Expired: January 29, 2024

Experts address audience questions from a live symposium on AML treatment strategies and future therapy directions, from Clinical Care Options (CCO)

Daniel Pollyea, MD, MS
Program Director Courtney DiNardo, MD, MSCE Eytan M. Stein, MD Released: January 24, 2023

Clinical Care Options (CCO): Expertos repasan los principales datos sobre LLC y LCM de las juntas de ASCO, EHA, la Conferencia Pan-Pacífico sobre Linfomas, ESMO y SOHO de 2022

Othman Al-Sawaf, MD Matthew S. Davids, MD, MMSc Toby Eyre, MBChB, MD Christopher R. Flowers, MD, MS Brad S. Kahl, MD Kami Maddocks, MD Anthony Mato, MD, MSCE Lydia Scarfò, MD Julie M. Vose, MD, MBA Released: January 23, 2023